Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.
<h4>Introduction</h4>Gene expression patterns characterizing clinically-relevant molecular subgroups of glioblastoma are difficult to reproduce. We suspect a combination of biological and analytic factors confounds interpretation of glioblastoma expression data. We seek to clarify the na...
Saved in:
Main Authors: | Nicholas F Marko, John Quackenbush, Robert J Weil |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/bcededc8d9224b12b89bd0cfcfb15dc8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
by: Claire Gazaille, et al.
Published: (2021) -
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
by: Sejin Oh, et al.
Published: (2020) -
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated <i>MGMT</i>
by: María del Mar Álvarez-Torres, et al.
Published: (2021) -
Hypoxia: The Cornerstone of Glioblastoma
by: Marta Domènech, et al.
Published: (2021) -
Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
by: Andrea Magali González-Mora, et al.
Published: (2021)